尹晨希,周菲菲,夏良平.恶性肿瘤患者血清中PKM2水平的诊断和预后预测价值[J].肿瘤学杂志,2013,19(7):565-569. |
恶性肿瘤患者血清中PKM2水平的诊断和预后预测价值 |
The Diagnostic and Prognostic Value of Serum PKM2 in Patients with Cancer |
投稿时间:2012-12-03 |
DOI:10.11735/j.issn.1671-170X.2013.07.B014 |
|
|
中文关键词: PKM2 肿瘤 诊断 预后 血清 |
英文关键词:PKM2 neoplasms diagnosis prognosis serum |
基金项目:国家自然科学基金项目(81272641) |
|
摘要点击次数: 2242 |
全文下载次数: 1313 |
中文摘要: |
摘 要:PKM2作为有氧糖酵解关键酶,与肿瘤发生发展密切相关,在其诊断、预后及治疗方面均有很好的临床应用价值。恶性肿瘤患者血清中PKM2的浓度显著高于非恶性肿瘤患者及正常人,但在不同亚型的泌尿系统肿瘤中PKM2的诊断价值不同;PKM2与传统肿瘤标志物联合时,能显著提高诊断的灵敏度和特异性; PKM2浓度的上升与OS和PFS降低相关;治疗有效时PKM2浓度随之下降。另外,基础研究提示PKM2是重要的治疗靶点。 |
英文摘要: |
Abstract: As a key enzyme of aerobic glycolysis,PKM2 closely relates to the generation and development of tumor,which has a crucial value of diagnosis,prognosis and treatment in clinical. In the aspect of diagnose,the density of serum PKM2 in cancer patients is significantly higher than that in nonmalignant disease patients,while the diagnostic value is different in various subtype of urogenital neoplasms; when associate with traditional tumor markers,PKM2 shows an increasing sensitivity and specific ability of diagnosis. In the aspect of prognosis,the ascending of the PKM2 density is accompanied with the descending of OS and PFS; the density of PKM2 will descend while the treatment is effective. In the aspect of treatment,there are several studies prompt that PKM2 is an important target for treatment. |
在线阅读
查看全文 查看/发表评论 下载PDF阅读器 |